Table 5.
Subgroup analysis for SMD of circulating vitamin E level in MetS vs. control subjects.
Stratification | Number of studies | Pooled SMD | 95% CI | P-value | Heterogeneity |
---|---|---|---|---|---|
All studies | 10 | −0.58 | −1.04, −0.13 | P = 0.01 | P < 0.001; I2 = 99% |
Assessment of outcome | |||||
HPLC | 9 | −0.24 | −0.64, 0.12 | P = 0.17 | P < 0.001; I2 = 99% |
Spectrophotometric method | 1 | −4.67 | −5.14, −4.20 | / | / |
Study quality | |||||
High quality | 8 | −1.00 | −1.54, −0.45 | P < 0.001 | P < 0.001; I2 = 99% |
Low quality | 2 | 0.44 | −0.15, 1.02 | P = 0.14 | P = 0.01; I2 = 73% |
Type of tocopherol | |||||
α-tocopherol | 3 | 0.08 | −0.16, 0.33 | P = 0.50 | P = 0.03; I2 = 72% |
γ-tocopherol | 2 | 0.54 | −1.03, 2.11 | P = 0.50 | P = 0.004; I2 = 88% |